Novo Nordisk today announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with haemophilia A with and without inhibitors. The trial initially assessed ...

Destination DC (DDC), the official destination marketing organisation for the US capital, has recognised nine industry experts for creating a positive impact in the city and for bringing meetings ...

Phase 3 FRONTIER3 interim analysis data presented at EAHAD 2025 showed that 74.3% of children on once-weekly Mim8 prophylaxis experienced zero treated bleeds ...

An 80-year-old Brit who found himself in a life-or-death battle with unstoppable bleeding has made a full recovery after ...

Light has long been recognized as a critical regulator of human health, influencing everything from hormone secretion to cardiovascular rhythms. Published in the journal, Journal of Thrombosis and ...

Researchers at Oregon Health & Science University have made new discoveries about amniotic fluid, a substance historically ...

Quadratech Diagnostics introduces Factor-X Activator RVV-X globally: United Kingdom Tuesday, January 21, 2025, 16:00 Hrs [IST] Quadratech Diagnostics, a provider of high quality m ...

Andraska et al, Alterations in visible light exposure modulate platelet function and regulate thrombus formation, Journal of Thrombosis and Haemostasis (2024). DOI: 10.1016/j.jtha.2024.08.020 ...

Did you know that a woman has a greater chance of dying from a heart attack than from all forms of cancer combined? Or that ...